Nearly 120 million doses of Covid-19 vaccine would be available in June for the national vaccination programme, half of which would be supplied by the centre to states free of cost, the health ministry said in a statement on Sunday.
During June, the government would procure 60,960,000 doses for the inoculation of the priority group such as frontline healthcare workers and persons above 45 years of age.
In addition to this 58,610,000 doses would be available with vaccine makers for direct procurement by states and private hospitals.
The Health ministry said it would share the delivery schedule and allocation of doses to states in advance. The Centre has asked the states to direct the concerned officials to ensure rational and judicious use of allocated doses and minimise wastage.
“The basic objective behind informing the States in advance of the quantum of free vaccine doses to be made available from the Government of India for 15 or 30 days and the total vaccine doses which are available for direct procurement by states is to ensure better planning and delivery of vaccine,” the health ministry said.
In May the centre provided over 40 million vaccine doses to states. Another 39 million doses were procured directly either by states or private hospitals.
According to the health ministry data 79,405,200 doses were available for Covid vaccination during May.
A total of around 210 million doses have so far been administered as part of the Covid vaccination drive in the country.
Since May 1, the highest number of doses given on a single day was on Saturday with more than 3 million people getting their jab.
With more than 22 million doses administered so far, Maharashtra has taken a lead in the vaccination drive. Uttar Pradesh is next in line with over 18 million doses followed by Gujarat and Karnataka having given almost 17 million doses so far.
More than 185 millions of Covishield have been given to people and around 29 million doses of Covaxin. India now also has the Russian Sputnik V available for the people and over 7,400 of its doses have been administered to beneficiaries so far.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
Source link
